RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Liennews2024-07-22T12:58:00+00:00July 22nd, 2024|Medical Device News Magazine|
Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Diseasenews2024-07-18T09:23:27+00:00July 18th, 2024|Medical Device News Magazine|
Addex Therapeutics to Present at the Thirteenth London International Cough Symposium (13th LICS)news2024-07-12T08:52:32+00:00July 12th, 2024|Medical Device News Magazine|
Medsenic, a Subsidiary of BioSenic SA, Extends Key Patent to the United Statesnews2024-07-05T07:55:33+00:00July 5th, 2024|Medical Device News Magazine|
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ ®news2024-07-01T06:49:08+00:00July 1st, 2024|Medical Device News Magazine|
Bio-Rad Launches Celselect Slides 2.0 to Advance Rare Cell and Circulating Tumor Cell Enrichment for Cancer Researchnews2024-06-27T20:27:49+00:00June 27th, 2024|Medical Device News Magazine|
PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Veranews2024-06-25T17:02:37+00:00June 25th, 2024|Medical Device News Magazine|
SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Applicationnews2024-06-24T14:55:46+00:00June 24th, 2024|Medical Device News Magazine|
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001news2024-06-19T14:46:41+00:00June 19th, 2024|Medical Device News Magazine|
Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for Treatment of Relapsed or Refractory Peripheral T-Cell Lymphomanews2024-06-19T14:40:04+00:00June 19th, 2024|Medical Device News Magazine|